Publicacións nas que colabora con ANA ISABEL RODRIGUEZ PEREZ (19)

2024

  1. Non-HLA angiotensin-type-1 receptor autoantibodies mediate the long-term loss of grafted neurons in Parkinson’s disease models

    Stem Cell Research and Therapy, Vol. 15, Núm. 1

2022

  1. Angiotensin type-1 receptor and ACE2 autoantibodies in Parkinson´s disease

    npj Parkinson's Disease, Vol. 8, Núm. 1

  2. Microglial angiotensin type 2 receptors mediate sex-specific expression of inflammatory cytokines independently of circulating estrogen

    GLIA, Vol. 70, Núm. 12, pp. 2348-2360

2021

  1. An ACE2/Mas-related receptor MrgE axis in dopaminergic neuron mitochondria

    Redox Biology, Vol. 46

  2. Estrogen Deficiency and Colonic Function: Surgical Menopause and Sex Differences in Angiotensin and Dopamine Receptor Interaction

    The journals of gerontology. Series A, Biological sciences and medical sciences, Vol. 76, Núm. 9, pp. 1533-1541

  3. Experimental data using candesartan and captopril indicate no double-edged sword effect in COVID-19

    Clinical Science, Vol. 135, Núm. 3, pp. 465-481

  4. Interactions between ibuprofen, ACE2, renin‐angiotensin system, and spike protein in the lung. Implications for COVID‐19

    Clinical and Translational Medicine, Vol. 11, Núm. 4

2020

  1. Angiotensin type 2 receptors: Role in aging and neuroinflammation in the substantia nigra

    Brain, Behavior, and Immunity, Vol. 87, pp. 256-271

  2. Interaction between brain angiotensin and dopaminergic systems and Parkinson’s disease

    Genetics, Neurology, Behavior, and Diet in Parkinson’s Disease: The Neuroscience of Parkinson’s Disease, Volume 2 (Elsevier), pp. 463-477

2018

  1. Angiotensin Type 1 Receptor Antagonists Protect Against Alpha-Synuclein-Induced Neuroinflammation and Dopaminergic Neuron Death

    Neurotherapeutics, Vol. 15, Núm. 4, pp. 1063-1081

  2. Bidirectional Neural Interaction Between Central Dopaminergic and Gut Lesions in Parkinson’s Disease Models

    Molecular Neurobiology, Vol. 55, Núm. 9, pp. 7297-7316

2017

  1. Brain renin-angiotensin system and microglial polarization: Implications for aging and neurodegeneration

    Frontiers in Aging Neuroscience, Vol. 9, Núm. MAY

  2. Expression of angiotensinogen and receptors for angiotensin and prorenin in the rat and monkey striatal neurons and glial cells

    Brain Structure and Function, Vol. 222, Núm. 6, pp. 2559-2571

2016

  1. Crosstalk between insulin-like growth factor-1 and angiotensin-II in dopaminergic neurons and glial cells: Role in neuroinflammation and aging

    Oncotarget, Vol. 7, Núm. 21, pp. 30049-30067

2014

  1. Brain renin-angiotensin system and dopaminergic cell vulnerability

    Frontiers in Neuroanatomy, Vol. 8, Núm. JULY

2012

  1. Brain angiotensin and dopaminergic degeneration: Relevance to Parkinson’s disease

    American Journal of Neurodegenerative Diseases, Vol. 1, Núm. 3, pp. 226-244

  2. Involvement of PPAR-γ in the neuroprotective and anti-inflammatory effects of angiotensin type 1 receptor inhibition: Effects of the receptor antagonist telmisartan and receptor deletion in a mouse MPTP model of Parkinson's disease

    Journal of Neuroinflammation, Vol. 9

2011

  1. Aging, angiotensin system and dopaminergic degeneration in the substantia nigra

    Aging and Disease, Vol. 2, Núm. 3, pp. 257-274

  2. Renin angiotensin system and gender differences in dopaminergic degeneration

    Molecular Neurodegeneration, Vol. 6, Núm. 1